
UbiVac Presents 1st Report of In Vivo Generated T Cell Receptor (TCR) to Dark Genome-Derived Cancer’s Dark Matter
UbiVac’s DPV-001 induces Development of 1st in-patient generated TCR to Non-Small Cell Lung Cancer’s “Dark Matter” – Targets cancer without apparent toxicity HONOLULU, HI, UNITED STATES, May 5, 2025 /EINPresswire.com/ -- UbiVac, www.ubivac.com, …